{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:54:37Z","timestamp":1790754877900,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970586"],"award-info":[{"award-number":["81970586"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2500200"],"award-info":[{"award-number":["2021YFC2500200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Department of Science and Technology of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.kint.2025.01.041","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T16:17:36Z","timestamp":1743265056000},"page":"1002-1010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Risk stratification of metabolic disorder\u2013associated kidney disease"],"prefix":"10.1016","volume":"107","author":[{"given":"Xin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan Fan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2025.01.041_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Suppl (2011)"},{"key":"10.1016\/j.kint.2025.01.041_bib2","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Risk Factors. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","author":"Collaborators","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2025.01.041_bib3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2025.01.041_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamainternmed.2022.6817","article-title":"Prevalence of chronic kidney disease in China: results from the sixth China Chronic Disease and Risk Factor Surveillance","volume":"183","author":"Wang","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"suppl 1","key":"10.1016\/j.kint.2025.01.041_bib5","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1053\/j.ajkd.2024.01.001","article-title":"US Renal Data System 2023 Annual Data Report: epidemiology of kidney disease in the United States","volume":"83","author":"Johansen","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.01.041_bib6","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2025.01.041_bib7","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.3390\/cells11213443","article-title":"Cellular senescence in metabolic-associated kidney disease: an update","volume":"11","author":"Gao","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.kint.2025.01.041_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2022-002806","article-title":"Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria","volume":"10","author":"McGill","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.kint.2025.01.041_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ekir.2023.10.006","article-title":"Updates on new therapies for patients with CKD","volume":"9","author":"Tarun","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2025.01.041_bib10","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"Epidemiology Task Force Consensus. The metabolic syndrome\u2014a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2025.01.041_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40200-023-01348-5","article-title":"Metabolic syndrome as a risk factor for the development of kidney dysfunction: a meta-analysis of observational cohort studies","volume":"23","author":"Valizadeh","year":"2024","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.kint.2025.01.041_bib12","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3390\/jcm12041614","article-title":"The effect of metabolic syndrome and its individual components on renal function: a meta-analysis","volume":"12","author":"Li","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.kint.2025.01.041_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.ki.5002586","article-title":"Association between obesity and kidney disease: a systematic review and meta-analysis","volume":"73","author":"Wang","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.01.041_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41574-024-00951-7","article-title":"Obesity and the kidney: mechanistic links and therapeutic advances","volume":"20","author":"Yau","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.kint.2025.01.041_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","article-title":"Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease","volume":"2","author":"de Vries","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2025.01.041_bib16","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1002\/j.2040-4603.2023.tb00281.x","article-title":"Insulin resistance and insulin handling in chronic kidney disease","volume":"13","author":"Parvathareddy","year":"2023","journal-title":"Compr Physiol"},{"key":"10.1016\/j.kint.2025.01.041_bib17","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.3390\/nu13124349","article-title":"Role and treatment of insulin resistance in patients with chronic kidney disease: a review","volume":"13","author":"Nakashima","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.kint.2025.01.041_bib18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","article-title":"Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease","volume":"19","author":"Mitrofanova","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2025.01.041_bib19","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.ajpath.2015.04.007","article-title":"Podocyte injury\u2013driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis","volume":"185","author":"Hara","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2025.01.041_bib20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13098-023-01214-7","article-title":"Comparison of METS-IR and HOMA-IR for predicting new-onset CKD in middle-aged and older adults","volume":"15","author":"Yoon","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.kint.2025.01.041_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S2213-8587(13)70199-2","article-title":"Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study","volume":"2","author":"Selvin","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2025.01.041_bib22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/j.ajkd.2022.02.016","article-title":"Association of uremic solutes with cardiovascular death in diabetic kidney disease","volume":"80","author":"Sapa","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.01.041_bib23","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.3390\/jcm10184129","article-title":"Alpha-1 acid glycoprotein and podocin mRNA as novel biomarkers for early glomerular injury in obese children","volume":"10","author":"Medy\u0144ska","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.kint.2025.01.041_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40620-015-0199-8","article-title":"Urinary Podocalyxin, the novel biomarker for detecting early renal change in obesity","volume":"29","author":"Suwanpen","year":"2016","journal-title":"J Nephrol"},{"key":"10.1016\/j.kint.2025.01.041_bib25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jmri.26003","article-title":"1H-MRS for the assessment of renal triglyceride content in humans at 3T: a primer and reproducibility study","volume":"48","author":"Dekkers","year":"2018","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.kint.2025.01.041_bib26","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.ekir.2023.01.031","article-title":"Identification of glomerular and plasma apolipoprotein M as novel biomarkers in glomerular disease","volume":"8","author":"Drexler","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2025.01.041_bib27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12882-020-02122-y","article-title":"Significance of urinary fatty acid-binding protein 4 level as a possible biomarker for the identification of minimal change disease in patents with nephrotic-range proteinuria","volume":"21","author":"Tanaka","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2025.01.041_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.821209","article-title":"Blood plasma metabolites in diabetes-associated chronic kidney disease: a focus on lipid profiles and cardiovascular risk","volume":"9","author":"Lecamwasam","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.kint.2025.01.041_bib29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jdiacomp.2014.12.012","article-title":"Soluble CD36 in plasma and urine: a plausible prognostic marker for diabetic nephropathy","volume":"29","author":"Shiju","year":"2015","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.kint.2025.01.041_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13646","article-title":"Metabolic syndrome severity score and the progression of CKD","volume":"52","author":"Wu","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.kint.2025.01.041_bib31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-17-0883","article-title":"METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes","volume":"178","author":"Bello-Chavolla","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.kint.2025.01.041_bib32","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.2147\/DMSO.S370222","article-title":"Metabolism Score for Visceral Fat (METS-VF): a new predictive surrogate for CKD risk","volume":"15","author":"Feng","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.kint.2025.01.041_bib33","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/joim.13355","article-title":"Association of the metabolic syndrome with mortality and major adverse cardiac events: a large chronic kidney disease cohort","volume":"290","author":"Pammer","year":"2021","journal-title":"J Intern Med"},{"key":"10.1016\/j.kint.2025.01.041_bib34","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2025.01.041_bib35","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2025.01.041_bib36","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2337\/dc22-0698","article-title":"Development and validation of prediction models of adverse kidney outcomes in the population with and without diabetes","volume":"45","author":"Grams","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2025.01.041_bib37","doi-asserted-by":"crossref","first-page":"731","DOI":"10.34067\/KID.0002252020","article-title":"Initial validation of a machine learning-derived prognostic test (KidneyIntelX) integrating biomarkers and electronic health record data to predict longitudinal kidney outcomes","volume":"1","author":"Chauhan","year":"2020","journal-title":"Kidney360"},{"key":"10.1016\/j.kint.2025.01.041_bib38","doi-asserted-by":"crossref","DOI":"10.1177\/21501319231223437","article-title":"A real-world precision medicine program including the KidneyIntelX test effectively changes management decisions and outcomes for patients with early-stage diabetic kidney disease","volume":"15","author":"Tokita","year":"2024","journal-title":"J Prim Care Community Health"},{"key":"10.1016\/j.kint.2025.01.041_bib39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jama.2015.18202","article-title":"Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis","volume":"315","author":"Tangri","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2025.01.041_bib40","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure","volume":"305","author":"Tangri","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2025.01.041_bib41","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.7150\/thno.80435","article-title":"Integration of metabolomics and peptidomics reveals distinct molecular landscape of human diabetic kidney disease","volume":"13","author":"Jiang","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.kint.2025.01.041_bib42","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2215\/CJN.02690320","article-title":"Decision algorithm for prescribing SGLT2 inhibitors and GLP-1 receptor agonists for diabetic kidney disease","volume":"15","author":"Li","year":"2020","journal-title":"Clin J of Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.01.041_bib43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12916-019-1340-7","article-title":"Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis","volume":"17","author":"Damen","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.kint.2025.01.041_bib44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/eurjpc\/zwab154","volume":"29","author":"Visseren","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"suppl 2","key":"10.1016\/j.kint.2025.01.041_bib45","first-page":"S49","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2025.01.041_bib46","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","author":"Rossing","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.01.041_bib47","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/joim.13640","article-title":"Precision medicine in complex diseases\u2014molecular subgrouping for improved prediction and treatment stratification","volume":"294","author":"Johansson","year":"2023","journal-title":"J Intern Med"},{"key":"10.1016\/j.kint.2025.01.041_bib48","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jacc.2023.07.018","article-title":"Performance of the ACC\/AHA pooled cohort cardiovascular risk equations in clinical practice","volume":"82","author":"Medina-Inojosa","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.kint.2025.01.041_bib49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.ajkd.2020.07.011","article-title":"Novel risk factors for progression of diabetic and nondiabetic CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"77","author":"Anderson","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.01.041_bib50","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00125-023-06027-x","article-title":"Multi-omic prediction of incident type 2 diabetes","volume":"67","author":"Carrasco-Zanini","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.kint.2025.01.041_bib51","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41587-022-01520-x","article-title":"Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models","volume":"41","author":"Allesoe","year":"2023","journal-title":"Nat Biotechnol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825002601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825002601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:41:27Z","timestamp":1762231287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253825002601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0085253825002601"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2025.01.041","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk stratification of metabolic disorder\u2013associated kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.01.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society of Nephrology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}